CompletedPhase NAResults posted

Gastrectomy, Eating Behaviour and GLP-1

The Effect of Glucagon Like Peptide-1 (GLP-1) on Glycaemic Profile and Eating Behaviour Following Gastrectomy

Lead sponsor

Cambridge University Hospitals NHS Foundation Trust

Asset

Avexitide

Listed sites

Recruiting sites

Actual enrollment

Study population

Eligibility highlights

Primary endpoint

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT02971631

Org study IDA094265

Secondary ID218762IRAS

Timeline

Milestones

Study first posted2016-11-23estimated

Study start2017-08-10actual

Primary completion2018-09-16actual

Study completion2018-09-16actual

Last update posted2019-08-29actual

Results first posted2019-08-29actual

Assets

Investigational agents

Avexitide

Who can enroll

Minimum age18 Years

Maximum age100 Years

SexAll

Healthy volunteersNot accepted

Inclusion criteria

•• At least 3 months post completion of treatment for gastric cancer, or prophylactic gastrectomy

-Aged at least 18 years

-Able to tolerate an oral glucose tolerance test

-Able to understand and retain all information regarding the study and give informed consent.

-Willing to receive an infusion of human albumin solution

Exclusion criteria

•• Have a diagnosis of diabetes

-Have a history of untreated anaemia in the last 3 months

-Be aged under 18 years

-Have active gastric cancer

-Be pregnant or attempting to conceive

Endpoints (0)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

No endpoints recorded for this trial.

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableClinicalTrials.gov results section

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.